ANI Pharmaceuticals, Inc.
ANIP
$70.70
$0.470.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 68.65% | 110.11% | 94.96% | 77.11% | -9.53% |
| Total Receivables | 21.63% | 15.93% | 26.77% | 28.65% | 35.86% |
| Inventory | 3.49% | 4.41% | 4.59% | -1.06% | 10.26% |
| Prepaid Expenses | 106.74% | -5.36% | 27.89% | 6.23% | 8.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -30.06% | 0.85% | 1,299.13% | 49.71% | -89.39% |
| Total Current Assets | 36.97% | 39.31% | 42.51% | 33.97% | 8.49% |
|
|
|||||
| Total Current Assets | 36.97% | 39.31% | 42.51% | 33.97% | 8.49% |
| Net Property, Plant & Equipment | 23.59% | 15.36% | 9.87% | 12.09% | 14.73% |
| Long-term Investments | 3.22% | 3.00% | 4.15% | 3.40% | 114.50% |
| Goodwill | 3.22% | 3.00% | 4.15% | 3.40% | 114.50% |
| Total Other Intangibles | -13.54% | -13.25% | -11.50% | -12.29% | 184.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.11% | -20.92% | -12.22% | 8.12% | 5.60% |
| Total Assets | 11.25% | 10.02% | 12.14% | 9.38% | 45.86% |
|
|
|||||
| Total Accounts Payable | 35.30% | 31.35% | 37.08% | 14.62% | 12.10% |
| Total Accrued Expenses | 20.89% | 26.63% | 55.52% | 62.14% | 109.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 61.39% | 72.41% | 110.37% | 113.10% | 1,454.82% |
| Total Finance Division Other Current Liabilities | -9.37% | -15.00% | 10.86% | 30.55% | 51.02% |
| Total Other Current Liabilities | -9.37% | -15.00% | 10.86% | 30.55% | 51.02% |
| Total Current Liabilities | 19.77% | 18.68% | 43.02% | 42.45% | 69.19% |
|
|
|||||
| Total Current Liabilities | 19.77% | 18.68% | 43.02% | 42.45% | 69.19% |
| Long-Term Debt | -3.15% | -2.81% | -2.46% | -2.13% | 113.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 132.00% | 134.33% | -- | 62.30% | 43.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -71.05% | -67.54% | -73.04% | -62.78% | 166.11% |
| Total Liabilities | 1.76% | 1.26% | 5.11% | 5.34% | 100.25% |
|
|
|||||
| Common Stock & APIC | 14.46% | 14.57% | 14.70% | 14.74% | 1.77% |
| Retained Earnings | 140.47% | 107.52% | 76.97% | 43.54% | -18.20% |
| Treasury Stock & Other | -91.44% | -91.47% | -105.25% | -94.24% | -141.44% |
| Total Common Equity | 36.74% | 34.32% | 33.95% | 24.60% | -4.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 36.74% | 34.32% | 33.95% | 24.60% | -4.17% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.38% | 26.80% | 26.18% | 17.41% | -3.95% |
|
|
|||||